molecules molecules molecules molecules

Category: The Arcus Vision

The Arcus Vision|February 24, 2023

A Peek Into the Platform: How an Innovative Trial Design Can Accelerate Drug Development

To evaluate the growing number of treatment options for cancer efficiently and rigorously, we need to rethink the way we approach early clinical trials.

Dimitry S.A. Nuyten|Chief Medical Officer at Arcus Biosciences
Read More
The Arcus Vision|October 14, 2022

What Biotech Companies Can Learn from Consumer Tech Outliers

Patients are waiting, so life sciences companies must embrace change and evolve their thinking.

Jennifer Jarrett|Chief Operating Officer at Arcus Biosciences
Read More
The Arcus Vision|August 17, 2022

How do Biotechs Stay the Course in Uncharted Waters?

In the latest Beyond Borders: Ernst & Young’s biotechnology report 2022, Arcus Biosciences CEO Terry Rosen discusses the strategic partnership that put the company in a strong financial position to thrive during the turbulent market facing the biotech industry in 2022 and beyond.

Beyond Borders|EY biotechnology report 2022
Read More
The Arcus Vision|May 9, 2022

Combining to Cure: Arcus Founders Talk Strategy and Legacy

There are many examples of productive relationships in science and research. Think of James Watson and Francis Crick, or Marie and Pierre Curie.

Jo Shorthouse|Freelance writer and editor
Read More